New clinical investigations with selective angiotensin II receptor blocker therapy in diabetes and renal disease
Summary Halting the reduction in glomerular filtration rate (GFR) is the primary aim of any treatment of patients presenting with progressive chronic renal failure, a very common corollary to diabetes. To improve GFR, the high blood pressure (BP) and proteinuria often seen in these patients must bot...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2000-06-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.3317/JRAAS.2000.051 |